re: nrt chart = wrong decision I think we could get $10 per share dividends or more should Phenoxodiol work and get approved.
Look at Gleevec which only treats a small proportion of leukemias. They are already getting $1bn in revenue from this drug. Considering Leukemia is a fairly rare cancer the potential market is massive.
All we need it to start the ball rolling. Either with the trials at RNS in leukemia or Yale for Ovarian. I believe it's currently being tested in prostate cancer patients (oral version). More trials are set to start soon.
I wish we could have weekly updates with these current trials but it's just a matter of time till we see the results.
Cheers,
Munch.
- Forums
- ASX - By Stock
- nrt ..chart
re: nrt chart = wrong decision I think we could get $10 per...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)